Current topics in the news regarding human immodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS).

CDC supports the new World Health Organization (WHO) guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis (PrEP) for HIV
This early-release guideline makes available two key recommendations that were developed during the revision process in 2015. First, antiretroviral therapy (ART) should be initiated in everyone living with HIV at any CD4 cell count. Second, the use of daily oral PrEP is recommended as a prevention choice for people at substantial risk of HIV infection as part of combination prevention approaches. 

Ryan White HIV/AIDS Program Part B Proposal Information
On August 28, 2015, Commissioner Edward Ehlinger of MDH and Commissioner Lucinda Jesson of the Minnesota Department of Human Services (DHS) issued a joint letter announcing the community review of an administrative proposal to transfer the federal grant responsibilities for the Ryan White HIV/AIDS Program, Part B funds, from DHS to MDH.

Health officials urging men who have sex with men (MSM) to seek meningococcal vaccination following death of man from meningococcal meningitis
Meningococcal outbreaks among MSM have occurred in Chicago, New York, Los Angeles. July 2015

CDC Health Advisory: Ciprofloxacin- and Azithromycin-Nonsusceptible Shigellosis in the United States

Most cases have been reported among gay, bisexual, and other men who have sex with men (MSM) in Illinois, Minnesota, and Montana and among international travelers, but cases are also occurring among other populations. Shigellosis is very contagious and can spread quickly through communities and across different segments of the population. June 2015

2015 STD Treatment Guidelines available from CDC

Guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) have been updated by the Centers for Disease Control and Prevention (CDC).

2014 HIV/AIDS Surveillance Reports
Number and demographic characteristics of newly diagnosed HIV/AIDS cases in Minnesota.
- Recording of the 2014 HIV Surveillance Statistics webinar presentation

Minnesota Treatment Cascade for People Living with HIV/AIDS
As part of the National HIV/AIDS Strategy for the United States, MDH has calculated an HIV treatment cascade using HIV surveillance data. These calculations help us better understand the HIV epidemic and the disparities that exist in the delivery of care among HIV positive people in Minnesota.
April 2015

2014 STD Surveillance Statistics
Graphs, tables and text that describe trends in sexually transmitted diseases (STDs) in Minnesota. Includes data on: Chlamydia, Gonorrhea, Syphilis and Chancroid.
- Recording of the 2014 STD Surveillance Statistics webinar presentation

CDC Video: 9 in 10 new US HIV infections come from people not receiving HIV care
Video from the CDC on the importance of getting those unaware of their status in to care

Shigellosis Fact Sheet for Men who have Sex with Men (MSM)

The Minnesota Department of Health (MDH) has observed an increase in reported shigellosis infections in Minneapolis among men who have sex with men (MSM). Four (4) cases were diagnosed in November among white, non-Hispanic, MSM. Sexual contact is the likely route of transmission. Three cases were hospitalized, and two of the cases had been previously diagnosed with HIV infection.

MCH Field Experience, Summer 2013: Developing the protocol for the Fetal and Infant Mortality Review as it relates to perinatal transmission of HIV in Minnesota (FIMR/HIV)
Article at the University of Minnesota's Center for Leadership Education in Material and Child Public Health.

Epidemiological Profile of HIV/AIDS in Minnesota
The epidemiological (epi) profile presents data on the HIV epidemic in the state of Minnesota. The profile is intended to give the Community Cooperative Council on HIV/AIDS Prevention (CCCHAP) and the Minnesota HIV Services Planning Council (Planning Council).

MMWRs from the Centers for Disease Control and Prevention (CDC)

HIV/AIDS among Men Who Have Sex with Men in Minnesota
Men who have sex with men (MSM) and men who have sex with men and use injection drugs (MSM/IDU) remain at increased risk for HIV infection in MN.

Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota
The Minnesota Chlamydia Partnership (MCP) and the STD, HIV and TB Section of the Minnesota Department of Health (MDH) present the Strategy for Reducing and Preventing Chlamydia in Minnesota, the first-ever action plan to address the epidemic of the sexually transmitted disease chlamydia

Assessment of Minnesota HIV/AIDS Prevention Services for Gay, Bisexual, Transgender and Other Men who Have Sex with Men (MSM)

Dear Colleague Letter (PDF)
The Minnesota Department of Health (MDH) requests that you take a sexual history screen for syphilis, provide prevention counseling, and solicit partners when appropriate for all your male patients in light of an alarming 87 percent increase in early syphilis cases. February 2010

The Minnesota Chlamydia Partnership (MCP)
MDH participates as an active member in a community based organization, the Minnesota Chlamydia Partnership (MCP). Members of the MCP are leaders in public health, health care, community organizations, and youth organizations.

Minnesota African/African-American Women HIV Initiative (MAAAH)
MAAAH was formed to establish Black women as a funding priority in the State of Minnesota, address the issue of lack of services specific to Black women and youth, and to ensure sustainability of services for Black women.

STD Expedited Partner Therapy (EPT) information

CDC National HIV Incidence Estimates: Frequently Asked Questions

CDC's Morbidity and Mortality Weekly Report (MMWR)
This issue of MMWR describes the HIV/AIDS epidemic in the United States and notes important successes and current challenges in the prevention of HIV. Also includes the summary Twenty-Five Years of HIV/AIDS - United States, 1981-2006.

MDH HIV Subtype and Drug Resistance Surveillance
MDH, STD, HIV and TB Section and Public Health Laboratory have incorporated HIV drug resistance and subtype surveillance into routine HIV surveillance.

Content Notice: This site contains HIV or STD prevention messages that may not be appropriate for all audiences. Since HIV and other STDs are spread primarily through sexual practices or by sharing needles, prevention messages and programs may address these topics. If you are not seeking such information or may be offended by such materials, please exit this web site.

Updated Friday, October 02, 2015 at 10:52AM